FINWIRES · TerminalLIVE
FINWIRES

Heartseed Reports First Patient Dosed in Cardiac Remuscularization Therapy Trial

By

Heartseed (TYO:219A) said the first patient with dilated cardiomyopathy has been dosed in a domestic trial of its catheter-administered cell therapy HS-005.

The Independent Safety Monitoring Committee approved the trial's continuation for the dilated cardiomyopathy cohort following a review of four-week post-administration data from this case, according to a Tokyo bourse filing on Friday.

The company-sponsored study aims to expand the therapy's application beyond severe heart failure from ischaemic heart disease to include dilated cardiomyopathy, enrolling 14 patients across both disease cohorts.

Related Articles

Asia

Market Chatter: Samsung Electronics in Talks to Manufacture Google's Next-Gen AI Chips; Samsung Shares Jump 12%

Samsung Electronics (KRX:005930) is currently in discussions with Alphabet's Google to manufacture a part of its ​next-generation artificial intelligence (AI) processor, Reuters reported Thursday, citing people familiar with the matter.Google plans to have Taiwan Semiconductor Manufacturing Company (TPE:2330) manufacture the primary compute chip for its next-generation tensor processing unit, called Icefish, while Samsung Electronics may manufacture a memory interface component using its 2-nanometer process technology, the report said.Icefish is being developed in collaboration with MediaTek at present, with mass production possibly commencing in 2028, it said.Google and Samsung did not immediately reply to requests for comment from.Shares of Samsung Electronics jumped nearly 12% in recent trade, while those of TSMC added over 2%.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$KRX:005930$TPE:2330
Asia

Emmerson Resources Says Court Hearing on Pan African Resources Deal Set for June 19; Shares Rise 5%

Emmerson Resources (ASX:ERM) said the Supreme Court of Western Australia will hear an application by the company on June 19 to approve its proposed acquisition by Pan African Resources, according to a Friday filing with the Australian bourse.Shareholders of Emmerson will vote on the deal at a meeting scheduled for June 15.The company's shares gained 5% in recent Friday trade.

$ASX:ERM
Asia

HKC Prices Shenzhen IPO at 10.12 Yuan to Raise 7.39 Billion Yuan

HKC (SHE:001399) priced its initial public offering of 729.8 million shares on the Shenzhen bourse at 10.12 yuan apiece to raise 7.39 billion yuan, according to a notice on the bourse.Proceeds will fund initiatives to accelerate new technology development and expand production capacity in next-generation display technologies as well as boost capital and repay loans.Offline subscription payment and online subscription are scheduled on Friday.The technology company specializes in semiconductor displays.

$SHE:001399